Francesco de Rubertis
Chairman bei CENTESSA PHARMACEUTICALS PLC
Ursprung des Netzwerks ersten Grades von Francesco de Rubertis
Einheit | Art der Einheit | Industrie | |
---|---|---|---|
Medicxi Ventures (Jersey) Ltd.
Medicxi Ventures (Jersey) Ltd. Investment ManagersFinance Medicxi Ventures (Jersey) Ltd. (Medicxi) is an independent venture capital firm founded in 2016 by Francesco de Rubertis, Michèle Ollier, and Kevin S. Johnson. The firm is headquartered in London.
25
| Private Company | Investment Managers | 25 |
Public Company | Pharmaceuticals: Major | 24 | |
Public Company | Pharmaceuticals: Major | 18 | |
Index Ventures (UK) LLP
18
| Subsidiary | Investment Managers | 18 |
BioXell SpA
BioXell SpA BiotechnologyHealth Technology BioXell SpA provides medical services. The company researches and develops drugs to treat urological, inflammatory, and related disorders. The company was founded in 2002 and is headquartered in Segrate, Italy.
17
| Extinct | Biotechnology | 17 |
University of Geneva
16
| College/University | Other Consumer Services | 16 |
Versartis, Inc.
Versartis, Inc. Pharmaceuticals: MajorHealth Technology Versartis, Inc. is an endocrine-focused biopharmaceutical company, which engages in the research and development of pharmaceutical products. Its portfolio includes Somavartan and XTEN TEchnology which target the endocrine disorders and growth hormone deficiencies. The company was founded by Jeffrey L. Cleland, Mark de Boer, Willem Stemmer, Volker Schellenberger, and Joshua Silverman on December 10, 2008 and is headquartered in Menlo Park, CA.
9
| Extinct | Pharmaceuticals: Major | 9 |
Synox Therapeutics Ltd.
Synox Therapeutics Ltd. BiotechnologyHealth Technology Synox Therapeutics Ltd. a clinical stage biopharmaceutical company. The company is headquartered in Dublin, Ireland.
7
| Holding Company | Biotechnology | 7 |
Levicept Ltd.
Levicept Ltd. Pharmaceuticals: GenericHealth Technology Levicept Ltd. develops a biological therapy for the treatment of osteoarthritis and chronic pain. Its treatments include p75NTR-Fc and LEVI-04. The company was founded by Simon Lempriere Westbrook on August 23, 2012 and is headquartered in Sandwich, the United Kingdom.
7
| Holding Company | Pharmaceuticals: Generic | 7 |
Xenikos BV
Xenikos BV Medical SpecialtiesHealth Technology Xenikos BV focuses on the development of immunotherapies for the treatment of patients suffering from immune diseases. It is developing a combination of two toxin-loaded anti-T-cell antibodies, T-Guard, as a therapeutic tool for resetting the body's immune system in T-cell mediated diseases. The company was founded by Ypek van Oosterhout in September 2009 and is headquartered in Nijmegen, the Netherlands.
5
| Holding Company | Medical Specialties | 5 |
Hamilton Pharmaceuticals, Inc.
Hamilton Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Hamilton Pharmaceuticals, Inc. develops and supplies pharmaceuticals. It also develops and commercializes novel medical treatments for central nervous system disease. The company was founded in April 2004 and is headquartered in Washington, DC.
5
| Subsidiary | Miscellaneous Commercial Services | 5 |
SDS Therapeutics Ltd.
SDS Therapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services SDS Therapeutics Ltd. is a British biotechnology company founded in 2020 that provides research and development services. The company is based in Cambridge, UK.
4
| Holding Company | Miscellaneous Commercial Services | 4 |
Inexia Ltd.
Inexia Ltd. Medical SpecialtiesHealth Technology Inexia Ltd. develops intranasal orexin positive modulators for the treatment of narcolepsy. The company is headquartered in London, the United Kingdom.
3
| Holding Company | Medical Specialties | 3 |
Critical Pressure Ltd.
Critical Pressure Ltd. Pharmaceuticals: MajorHealth Technology Critical Pressure Ltd. engages in research and experimental development on biotechnology. The firm develops products to treat vascular dysfunction and shock. The company is headquartered in Babraham, the United Kingdom.
3
| Holding Company | Pharmaceuticals: Major | 3 |
Rivus Pharmaceuticals, Inc.
Rivus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Rivus Pharmaceuticals, Inc. is a company dedicated to improving metabolic health by advancing a new class of medicines called controlled metabolic accelerators (CMAs). The company is based in Charlottesville, VA. Jayson Donald Alexander Dallas has been the CEO of the company since 2021. The company is a leader in mitochondrial biology and is developing a new class of medicines to address a primary driver of cardio-metabolic disease: obesity. Rivus' lead CMA is the investigational small molecule HU6 in development to treat obesity and associated metabolic diseases, including heart failure with preserved ejection fraction (HFpEF), metabolic dysfunction-associated steatotic liver disease (MASLD)/metabolic dysfunction-associated steatohepatitis (MASH), and type 2 diabetes.
3
| Holding Company | Pharmaceuticals: Major | 3 |
Egalet A/S
Egalet A/S Pharmaceuticals: MajorHealth Technology Egalet A/S operates as a specialty pharmaceuticals company. It develops opioid formulations for pain management based on abuse deterrent prolonged release erosion matrix technology in Denmark. The company develops prolonged and delayed release therapeutics for chronic pain management, including Parvulet, a delivery platform for facilitating dispensing of oral doses to pediatric and geriatric patient segments; and Egalet morphine. The company was founded by Jan Quistgaard in 1995 and is headquartered in Vaerloese, Denmark.
3
| Subsidiary | Pharmaceuticals: Major | 3 |
Orexia Therapeutics Ltd.
Orexia Therapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services Orexia Ltd. develop orally administered orexin positive modulators for the treatment of neurological diseases. The company was founded on October 5, 2018 and is headquartered in London, the United Kingdom.
2
| Subsidiary | Miscellaneous Commercial Services | 2 |
UltraHuman Ltd.
UltraHuman Ltd. Miscellaneous Commercial ServicesCommercial Services UltraHuman Ltd. engages in research and experimental development on biotechnology. The company is headquartered in Sandwich, the United Kingdom.
2
| Holding Company | Miscellaneous Commercial Services | 2 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Francesco de Rubertis
Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
---|---|---|---|
PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Human Resources Officer Director of Finance/CFO | |
ASTRAZENECA PLC | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
BIOGEN INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Human Resources Officer | |
AMARIN CORPORATION PLC | Pharmaceuticals: Major | Director/Board Member Comptroller/Controller/Auditor Director/Board Member | |
COMPUGEN LTD. | Biotechnology | Chairman Director/Board Member | |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Medical Specialties | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
University of Notre Dame | College/University | Undergraduate Degree Undergraduate Degree | |
AEGERION PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
IPSEN | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member | |
F-Star Biotechnologische Forschungs- Und Entwicklungsges MBH
F-Star Biotechnologische Forschungs- Und Entwicklungsges MBH Medical SpecialtiesHealth Technology F-Star Biotechnologische Forschungs- Und Entwicklungsges MBH develops improved therapeutic antibodies and antibody fragments for cancer. It is a biopharmaceutical company dedicated to developing novel bispecific antibody products that significantly improve on the current standard of care for patients with serious diseases such as cancer. The firm's modular antibody technology allows them to rapidly discover and develop bispecific antibodies by introducing additional binding sites to the constant region of an antibody. The company was founded by Florian Ruker, Gordana Wozniak-Knopp, and Gottfried Himmler on June 12, 2006 and is headquartered in Vienna, Austria. | Medical Specialties | Director/Board Member Chief Executive Officer | |
OANDA Corp.
OANDA Corp. Packaged SoftwareTechnology Services OANDA Corp. provides currency data, foreign exchange and contract for difference trading, payment, and data services for businesses and investors. The firm operates an online foreign exchange trading platform, FXTrade, which provides real-time access to the foreign exchange market. The company was founded by Richard Olsen and Michael Stumm in 1996 and is headquartered in San Francisco, CA. | Packaged Software | Director/Board Member Director/Board Member | |
VEEVA SYSTEMS INC. | Packaged Software | Director/Board Member Director/Board Member | |
University of Washington
University of Washington Other Consumer ServicesConsumer Services University of Washington functions as a College/University. The company is headquartered in Seattle, WA. | College/University | Graduate Degree Doctorate Degree | |
University of Melbourne
University of Melbourne Other Consumer ServicesConsumer Services The University of Melbourne, founded in 1853, is a world-renowned institution located in Parkville, Australia. The university is a leader in education, teaching, and research, offering a wide range of coursework and research programs. | College/University | Corporate Officer/Principal Doctorate Degree | |
University of Oxford | College/University | Corporate Officer/Principal Undergraduate Degree Doctorate Degree Graduate Degree Undergraduate Degree | |
Imperial College London | College/University | Undergraduate Degree Doctorate Degree Doctorate Degree | |
Index Ventures SA
Index Ventures SA Investment ManagersFinance Index Ventures SA (Index Ventures) is a venture capital firm founded in 1996 by Neil Alexander Rimer, Gluseppe Zocco and Gerald Rimer. The firm is headquartered in Geneva, Switzerland. | Investment Managers | Founder Private Equity Investor Private Equity Analyst Private Equity Investor Private Equity Investor Private Equity Analyst Private Equity Investor Private Equity Analyst | |
University of Cambridge | College/University | Doctorate Degree Doctorate Degree Corporate Officer/Principal Graduate Degree Graduate Degree | |
Massachusetts Institute of Technology | College/University | Doctorate Degree Undergraduate Degree Doctorate Degree | |
California Institute of Technology
California Institute of Technology Other Consumer ServicesConsumer Services California Institute of Technology provides education focusing on science, engineering, academia, business, and public service. The company was founded in 1891 and it is headquartered in Pasadena, CA. | College/University | Undergraduate Degree Undergraduate Degree | |
INSEAD | College/University | Masters Business Admin Corporate Officer/Principal | |
University of Lausanne | College/University | Corporate Officer/Principal Corporate Officer/Principal Doctorate Degree | |
New Leaf Venture Partners LLC
New Leaf Venture Partners LLC Investment ManagersFinance New Leaf Venture Partners LLC (New Leaf Ventures) is an independent Venture Capital firm founded by Jeani Delagardelle, Philippe Chambon, Vijay Lathi, Ron Hunt, James Niedel, and Kathy LaPorte. The firm is headquartered in New York. It spun out from Sprout Group. | Investment Managers | Private Equity Investor Corporate Officer/Principal Private Equity Investor | |
The Swiss Institute of Bioinformatics
The Swiss Institute of Bioinformatics Miscellaneous Commercial ServicesCommercial Services The Swiss Institute of Bioinformatics is an academic not-for-profit organization based in Basel, Switzerland. The institute provides over 160 high-quality databases and software tools to the life science community. Its mission is to lead and coordinate the field of bioinformatics. SIB experts and resources are involved in developing dedicated data services, analysis tools, and improving knowledge sharing to fight the COVID-19 pandemic. The institute has established close partnerships and collaborations with leading institutions at national and international levels. SIB values equality, diversity, and inclusion and trains the next generation of bioinformaticians to ensure that life scientists make the best use of bioinformatics and SIB's resources. | Miscellaneous Commercial Services | Director/Board Member Corporate Officer/Principal | |
SAGENT PHARMACEUTICALS INC | Pharmaceuticals: Major | Director/Board Member Chairman | |
Swiss Finance Institute | College/University | Chief Tech/Sci/R&D Officer President | |
Stealthyx Therapeutics Ltd.
Stealthyx Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Stealthyx Therapeutics Ltd. operates drug delivery system technology. The company was founded by Yuti Chernajovsky and Eileen Janis Anderson in 2002 and is headquartered in London, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member Chairman | |
ProFibrix BV
ProFibrix BV BiotechnologyHealth Technology ProFibrix BV develops and markets products for the hemostasis and regenerative medicine markets. Its product in pipeline, ProFibrix, is a hemostatic agent for mild to moderate surgical bleeding. The firm operates through its offices located in Leiden and Seattle. It is a subsidiary of The Medicines Company. The company was founded in 2004 by Jaap Koopman and is headquartered in Leiden, the Netherlands. | Biotechnology | Director/Board Member Director/Board Member | |
Harvard Medical School | College/University | Doctorate Degree Doctorate Degree Corporate Officer/Principal | |
SIX Swiss Exchange AG
SIX Swiss Exchange AG Investment Banks/BrokersFinance SIX Swiss Exchange AG operates as a stock exchange. It distributes a range of indices; and offers market data for shares, bonds, ETFs and funds, ETPs, indices, statistics, and data services. The firm enables to list and trade in segments, including equities, bonds, exchange traded funds (ETFs), exchange traded products (ETPs), derivatives, sponsored funds, sponsored foreign shares, warrants, and structured products. The company was founded in 1850 and is headquartered in Zurich, Switzerland. | Investment Banks/Brokers | Corporate Officer/Principal Corporate Officer/Principal | |
Mind-NRG SARL
Mind-NRG SARL Medical/Nursing ServicesHealth Services Mind-NRG SARL specializes in research and development programs with focus on the treatment psychiatric and neurologic diseases. The company was founded in 2010 and is headquartered in Geneva, Switzerland. | Medical/Nursing Services | President Chairman Director/Board Member Director/Board Member | |
Azek AG
Azek AG Miscellaneous Commercial ServicesCommercial Services Azek AG offers various training programs for Swiss financial professionals, including courses such as CIIA, CIWM, ESG, CESGA, ESG-CA, FINSA, FMO, and FMT. The private company is based in Bulach, Switzerland. Upon completion, successful participants are awarded the Federal Diploma of Technician in Financial Market Operations (FMT). Additionally, the ESG-CA course qualifies advisors to competently inform their clients about ESG and suggest sustainable investment solutions. The CEO of the Swiss company is Andreas Jacobs. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
Ashworth & Parker Ltd.
Ashworth & Parker Ltd. Apparel/Footwear RetailRetail Trade Ashworth & Parker Ltd. provides online shopping services. It offers cloths, footwear, bags, belts, hats, scarves, gloves, socks, sunglasses, jewelry, watches, and wallets & key chains. The company was founded in 2005 and is headquartered in Newcastle upon Tyne, the United Kingdom. | Apparel/Footwear Retail | Director/Board Member Director/Board Member | |
Morphogen-IX Ltd.
Morphogen-IX Ltd. Miscellaneous Commercial ServicesCommercial Services Morphogen-IX Ltd. operates as a biotechnology company. It develops bone morphogenetic proteins as a novel therapy for the treatment of Pulmonary Arterial Hypertension. The company was founded in 2015 and is headquartered in Babraham, the United Kingdom. | Miscellaneous Commercial Services | Director/Board Member Founder | |
Capella Bioscience Ltd.
Capella Bioscience Ltd. Pharmaceuticals: MajorHealth Technology Capella Bioscience Ltd. develops medicines based on monoclonal antibodies to the next generation therapeutic targets in oncology and autoimmune disease. The company was founded by Steve Holmes in 2014 and is headquartered in London, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member | |
Inhibitaxin Ltd.
Inhibitaxin Ltd. BiotechnologyHealth Technology Inhibitaxin Ltd. engages in research and development on biotechnology. The company was founded by Simon Lempriere Westbrook and Kevin S. Johnson in 2013 and is headquartered in Kent, the United Kingodm. | Biotechnology | Founder Director/Board Member Founder | |
Z Factor Ltd.
Z Factor Ltd. BiotechnologyHealth Technology Z Factor Ltd. operates as a drug discovery company. It identifies and develops therapeutic agents to treat alpha-1-antitrypsin deficiency. The company was founded by James Huntington in 2015 and is headquartered in Babraham, the united Kingdom. | Biotechnology | Director/Board Member Director/Board Member Director/Board Member Founder | |
ApcinteX Ltd.
ApcinteX Ltd. BiotechnologyHealth Technology ApcinteX Ltd. develops and markets anticoagulant APC pathway to treat haemophilia. The company is headquartered in London, the United Kingdom. | Biotechnology | Director/Board Member Director/Board Member Founder | |
BioMed Valley Discoveries, Inc.
BioMed Valley Discoveries, Inc. Miscellaneous Commercial ServicesCommercial Services BioMed Valley Discoveries, Inc. is a biotechnology company that develops therapies for cancer, inflammation, and infectious disease. The private company is based in Kansas City, MO. The company was founded by Saurabh Saha. | Miscellaneous Commercial Services | Founder Chief Executive Officer | |
Rebalance (Cambridge) Ltd.
Rebalance (Cambridge) Ltd. Miscellaneous Commercial ServicesCommercial Services Rebalance (Cambridge) Ltd. provides research and experimental development on biotechnology. The company was founded on December 6, 2016 and is headquartered in Hatfield, the United Kingdom. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
ARAVIVE, INC. | Biotechnology | Chairman Chief Executive Officer Chief Administrative Officer Director of Finance/CFO | |
Amphista Therapeutics Ltd.
Amphista Therapeutics Ltd. BiotechnologyHealth Technology Amphista Therapeutics Ltd. is a biopharmaceutical company based in Biocity Glasgow, UK. The British company is focused on creating first-in-class therapeutics that selectively and efficiently degrade and remove disease-causing proteins using targeted protein degradation (TPD). The company's pipeline of novel small molecules is focused on challenging diseases, including cancer. Amphista is a spin-out of Professor Alessio Ciulli's labs at the University of Dundee and is funded by leading life science investors, including Advent Life Sciences, the European Investment Fund, the Scottish Investment Bank, and Biomotiv. The CEO of the company is Nicola Thompson. | Biotechnology | Director/Board Member Chairman | |
F-star Therapeutics Ltd.
F-star Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology F-Star Therapeutics Ltd. is a biopharmaceutical company, which engages in the development of immune-oncology drugs for antibody therapies. The company was founded in 2006 and is headquartered in Cambridge, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer | |
Scorpion Therapeutics, Inc.
Scorpion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Scorpion Therapeutics, Inc. provides health care services. The company is headquartered in Boston, MA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
F-STAR THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer |
Statistik
International
Vereinigte Staaten | 18 |
Vereinigtes Königreich | 18 |
Schweiz | 9 |
Frankreich | 3 |
Niederlande | 3 |
Sektoral
Health Technology | 25 |
Consumer Services | 12 |
Commercial Services | 7 |
Finance | 5 |
Technology Services | 4 |
Operativ
Director/Board Member | 648 |
Corporate Officer/Principal | 209 |
Independent Dir/Board Member | 107 |
Founder | 83 |
Chief Executive Officer | 78 |
Am stärksten vernetzte Beziehungen
Insiders | |
---|---|
Paul Sekhri | 62 |
Daniel H. Rimer | 55 |
Srini Akkaraju Akkaraju | 54 |
Raj Bhikhu Parekh | 50 |
Eliot Forster | 35 |
Michèle Ollier | 33 |
Jay Shepard | 30 |
Bob Flanagan Flanagan | 30 |
David Grainger | 29 |
Jean-Pierre Danthine | 27 |
Giuseppe Zocco | 26 |
Douglas Williams | 25 |
Mary Lynne Hedley | 25 |
Brett Zbar | 23 |
Frank Kung | 22 |
- Börse
- Insiders
- Francesco de Rubertis
- Unternehmensverbindungen